Kedudukan dalam Saham
#27702
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Perubahan (1 tahun)
-61.30%
Perdagangan IMBdx (461030)
Harga 461030 dengan permodalan pasaran b
Modal pasaran bagi IMBdx(461030)
Modal Pasaran: $31.27M
Sehingga August 2026, IMBdx mempunyai modal pasaran sebanyak $31.27M. Ini menjadikan IMBdx syarikat ke-27702nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran IMBdx dari 2024 hingga 2026
461030 berbanding dengan 5 teratas yang paling popular stocks
| Harga 461030 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+16,949,060.58%
|
|
|
|
|
$4.634T
|
+14,816,374.31%
|
|
|
|
|
$4.143T
|
+13,246,795.96%
|
|
|
|
|
$3.589T
|
+11,476,672.38%
|
|
|
|
|
$2.857T
|
+9,134,796.65%
|
